Search

 
 
 
Gold-nanoparticle-based Multifunctional Vehicle to Deliver Gene Therapeutics

GOLD-NANOPARTICLE-BASED MULTIFUNCTIONAL VEHICLE TO DELIVER GENE THERAPEUTICS

Thermo-triggered release of a genome-editing machinery by modified gold nanoparticles for tumor therapy.

Anatomy of two biotech deals worth $20B

ANATOMY OF TWO BIOTECH DEALS WORTH $20B

Analysts had forecast a blockbuster year for life science M&As, with the tax reforms taking effect and Big Pharma scrambling for late-stage...

 
 
 

HIRING CANCER BIOLOGIST

Nivien Therapeutics is a preclinical startup developing first-in-class drugs for treatment-resistant cancers based on new research...

WHAT YOU NEED TO KNOW ABOUT INDALO THERAPEUTICS

Indalo Therapeutics is based in St. Louis and was formed in October 2016 from the merger of Antegrin Therapeutics and Cascadia Therapeutics.

 
 
 
Two drug companies are exploding after a pair of biotech mega-deals

TWO DRUG COMPANIES ARE EXPLODING AFTER A PAIR OF BIOTECH MEGA-DEALS

Markets Insider French drugmaker Sanofi is acquiring biotech company Bioverativ in a $11.6 billion deal. Celgene is acquiring Juno...

WHY SPARK AND WATCHDOG ICER DON'T SEE EYE-TO-EYE ON $850K GENE THERAPY

The first gene therapy approved in the U.S. costs $850,000. Announcing the price on Jan. 3, its owner Spark Therapeutics held out the...

 
 
 
Celgene is buying cancer drugmaker Juno Therapeutics for $9 billion

CELGENE IS BUYING CANCER DRUGMAKER JUNO THERAPEUTICS FOR $9 BILLION

Celgene is acquiring Juno Therapeutics, a company developing personalized cancer treatments in a deal worth $9 billion. It's the second...

PRECISION FLUORESCENT LABELING OF AN ADENO-ASSOCIATED VIRUS VECTOR TO MONITOR THE VIRAL INFECTION PATHWAY

Adeno-associated virus 2 is a common vehicle for the delivery of a variety of therapeutic genes. A better understanding of the process...

 
 
 

SENIOR DIRECTOR, RESEARCH - REGULUS THERAPEUTICS INC - SAN DIEGO, CA

Experience leading a mid-size biology or drug discovery group in a biotechnology or pharmaceutical company ...From Regulus Therapeutics...

 
 
 
CRISPR Recovery? “Furor” Briefly Snips $500M From Companies' Values

CRISPR RECOVERY? “FUROR” BRIEFLY SNIPS $500M FROM COMPANIES' VALUES

Is the J.P. Morgan CRISPR rollercoaster ride over? As rain fell heavily in San Francisco Monday, the first day of the massive healthcare...

 
 
 
Pharmacy Revenues Decline, Thanks to Cheaper Medicines

PHARMACY REVENUES DECLINE, THANKS TO CHEAPER MEDICINES

We've been saying it for some time , and the numbers speak for themselves : spending on prescription drugs is heading in the right...

 
 
 
Alder Plans for FDA Filing After Migraine Drug Posts Strong Results

ALDER PLANS FOR FDA FILING AFTER MIGRAINE DRUG POSTS STRONG RESULTS

Alder Therapeutics' migraine-prevention drug hit its main goal in a late-stage study, and the drug developer these early results keep...

SANGAMO THERAPEUTICS OUTLINES 2018 KEY PRIORITIES AND CATALYSTS AT J.P. MORGAN HEALTHCARE CONFERENCE

RICHMOND, Calif., Jan. 8, 2018 /PRNewswire/ - In meetings with investors this week and during a presentation Wednesday at the J.P....

 
 
 
Ultrasound Tracks Therapeutic Microbes Deep Inside the Body

ULTRASOUND TRACKS THERAPEUTIC MICROBES DEEP INSIDE THE BODY

Sound-based imaging reveals the location of engineered bacteria inside the gut or in tumors

Gene therapy for blindness will cost $850,000 

GENE THERAPY FOR BLINDNESS WILL COST $850,000 

Drug-maker Spark Therapeutics lowered the cost of its treatment for a rare form of blindness from $1 million, but at $850,000, the...